"
From 2012e.igem.org
m |
m |
||
| Line 22: | Line 22: | ||
</td> | </td> | ||
<td> | <td> | ||
| - | <p>Entrepreneurship in iGEM is about fostering the development of a new industry where the underlying technological platform | + | <p>Entrepreneurship in iGEM is about fostering the development of a new industry where Synthetic Biology is the underlying technological platform. As with any new industry, it is not clear which business plans will be the most successful. But, there are also more fundamental questions: What Business models will succeed, how will intellectual property affect company formation and funding, what skills are required at each stage of company’s life cycle, how will government policies promote or hinder new companies, what will be the social contract with Synthetic Biology companies, [Insert your question here]? |
<p> | <p> | ||
Revision as of 15:05, 6 February 2012
Please come back 06 February 2012 for final information
|
Entrepreneurship in iGEM is about fostering the development of a new industry where Synthetic Biology is the underlying technological platform. As with any new industry, it is not clear which business plans will be the most successful. But, there are also more fundamental questions: What Business models will succeed, how will intellectual property affect company formation and funding, what skills are required at each stage of company’s life cycle, how will government policies promote or hinder new companies, what will be the social contract with Synthetic Biology companies, [Insert your question here]?
For this first year we will be considering at least four tracks examining critical business, regulatory and market issues that will determine the path of the Synthetic Biology industry:
|
iGEM 2012 E starting up
|
Online registration for the iGEM 2012 Entrepreneurship Competition will be opening soon. Any questions can be directed to iGEM Headquarters (hq AT igem.org) or Jose J. Pacheco (jose AT igem.org). |
|
